Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lexapro escitalopram: Preliminary Phase III data

Top-line data from an 8-week, double-blind, U.S. Phase III trial in 316 adolescents (aged

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE